Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;99(6):1494-1496.
doi: 10.1016/j.kint.2021.04.010. Epub 2021 Apr 20.

Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won

Massimo Torreggiani  1 , Sophie Blanchi  2 , Antioco Fois  3 , Hafedh Fessi  4 , Giorgina Barbara Piccoli  3
Affiliations
Comment

Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won

Massimo Torreggiani et al. Kidney Int. 2021 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart. Ab, antibody; Anti-S, anti-spike.
See this image and copyright information in PMC

Comment on

References

    1. Cavaleri M., Enzmann H., Straus S. The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines. Lancet. 2021;397:355–357. - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed
    1. Manisty C., Otter A.D., Treibel T.A. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet. 2021;397:1057–1058. - PMC - PubMed
    1. Francis A., Baigent C., Ikizler T.A. The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action. Kidney Int. 2021;99:791–793. - PMC - PubMed
    1. Glenn D.A., Hegde A., Kotzen E. Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease. Kidney Int Rep. 2021;6:1407–1410. - PMC - PubMed